Skip to content
APOAPOAPOV80V80V80

Drawing based on the description in the official product monograph. No photo yet.

“80 mg Tablets are yellow, round, biconvex, film-coated tablets, engraved "APO" over "V80" on one side, other side plain, containing 80 mg of verapamil hydrochloride”

APO V80 pill

Pill with imprint APO V80 is yellow, round and has been identified as Verapamil Hydrochloride 80 mg. It is used for high blood pressure, atrial fibrillation (irregular heartbeat) and fast heartbeat (SVT). It is supplied by Aa Pharma Inc.

Sold in Canada

Verapamil Hydrochloride 80 mg

Brand
Aa-Verap
Imprint
APO V80
Strength
80 mg
Used for
High blood pressure, atrial fibrillation (irregular heartbeat) and fast heartbeat (SVT)
Color
Yellow
Shape
Round
Form
Tablet
Manufacturer
Aa Pharma Inc
Drug class
Calcium channel blocker (blood pressure and heart medicine)
Sold in
Canada
DIN
00782483

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Verapamil pills and guides

What is Verapamil used for?

Verapamil is used for high blood pressure, atrial fibrillation (irregular heartbeat), fast heartbeat (SVT) and heart attacks.

Medicine type
Calcium channel blocker (blood pressure and heart medicine)
Official uses from the US prescribing label

Verapamil Hydrochloride Tablets are indicated for the treatment of the following:

Angina 1. Angina at rest including: – Vasospastic (Prinzmetal’s variant) angina – Unstable (crescendo, pre-infarction) angina 2. Chronic stable angina (classic effort-associated angina)

Arrhythmias 1. In association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see WARNINGS: Accessory bypass tract ) 2. Prophylaxis of repetitive paroxysmal supraventricular tachycardia

Essential hypertension: Verapamil is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows APO V80. The parts can be split between the two sides, so turn the pill over and check both.
  • It is yellow, round.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Aa-Verap by Aa Pharma Inc.

In Canada: prescription only.

Ingredients

Active: Verapamil Hydrochloride

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Verapamil pills